首页> 外文期刊>Thorax: The Journal of the British Thoracic Society >The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation
【24h】

The histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation

机译:组蛋白脱乙酰基酶抑制剂曲古抑菌素A通过阻断2组先天性淋巴样细胞(ILC2)的激活来抑制鼠类先天性过敏性炎症

获取原文
获取原文并翻译 | 示例
       

摘要

Background Group 2 innate lymphoid cells (ILC2) are an important source of the type 2 cytokines interleukin (IL)-5 and IL-13 that are critical to the allergic airway phenotype. Previous studies reported that histone deacetylase (HDAC) inhibition by trichostatin A (TSA) downregulated adaptive allergic immune responses; however, the effect of HDAC inhibition on the early innate allergic immune response is unknown. Therefore, we investigated the effect of TSA on innate airway inflammation mediated by ILC2 activation.
机译:背景技术第2组先天淋巴样细胞(ILC2)是2型细胞因子白介素(IL)-5和IL-13的重要来源,它们对过敏性气道表型至关重要。先前的研究报道,曲古抑菌素A(TSA)对组蛋白脱乙酰基酶(HDAC)的抑制作用下调了适应性变态免疫反应。但是,HDAC抑制对早期先天性过敏性免疫反应的影响尚不清楚。因此,我们调查了TSA对ILC2激活介导的先天性气道炎症的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号